HistoRx, Brigham and Women’s Hospital, Gentel Biosciences, Eppendorf, Auguron, Proteomika, Nonlinear Dynamics, Geneva Bioinformatics, GeneGo, Merck, Hybrigenics | GenomeWeb
Brigham and Women’s Gives Cancer Researchers Access to HistoRx’s Aqua
 
Brigham and Women’s Hospital will make HistoRx’s Aqua technology for protein biomarker profiling available to more than 900 Dana-Farber/Harvard Cancer Center scientists serviced by the facility, HistoRx said last week.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.